EUVIMEDEUVIMED entdecken
Open Access

Equity in Neurotoxicity Care in the Era of Cancer Immunotherapy

Rosalina Magalhaes Pereira, Joshua A Budhu iD

Seminars in Neurology · 20.08.2026

DOI: 10.1055/a-2936-3979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Seminars in Neurology, erschienen am 20.08.2026. Verfasst von Rosalina Magalhaes Pereira und 1 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, Department of Neurology, New York, United States, New York. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractImmunotherapies such as chimeric antigen receptor T cell (CAR-T) therapy and immune checkpoint inhibitors have improved cancer survival but are associated with potentially severe neurotoxicities that can impair neurologic function, quality of life, and survival. Despite their growing use, substantial disparities persist in the recognition, diagnosis, and management of cancer therapy–related neurotoxicities, disproportionately affecting underserved populations. In this review, we apply the social–ecological model (SEM) to examine how factors across individual, interpersonal, organizational, community, and policy levels contribute to inequities in neurotoxicology care. We synthesize evidence on barriers to early detection and access to neurologic expertise and highlight emerging strategies to promote equity, including early symptom recognition, improved specialty access, and supportive institutional infrastructure. We also explore the potential of behavioral economics–informed approaches and artificial intelligence–enabled tools, including telemedicine and remote monitoring, as scalable strategies to reduce inequities in neurotoxicity care.

Autor:innen und Institutionen

  • Memorial Sloan Kettering Cancer Center, Department of Neurology, New York, United States, New York.
  • Weill Cornell Medical College, Department of Neurology, New York, United States, New York.

ORCID-Profile: Joshua A Budhu

Förderung

  • NCI NIH HHS

Zitieren

APA

Pereira, R. M., & Budhu, J. A. (2026). Equity in Neurotoxicity Care in the Era of Cancer Immunotherapy. Seminars in Neurology. https://doi.org/10.1055/a-2936-3979

Vancouver

Pereira RM, Budhu JA. Equity in Neurotoxicity Care in the Era of Cancer Immunotherapy. Seminars in Neurology. 2026. doi:10.1055/a-2936-3979

BibTeX
@article{Pereira2026,
  author = {Pereira, Rosalina Magalhaes and Budhu, Joshua A},
  title = {Equity in Neurotoxicity Care in the Era of Cancer Immunotherapy},
  journal = {Seminars in Neurology},
  year = {2026},
  doi = {10.1055/a-2936-3979}
}
Kostenlos starten →